Search
for
Sort by
Research 181–210 of 1000+
- Retinoid-mediated stimulation of steroid sulfatase activity in myeloid leukemic cell lines requires RARα and RXR and involves the phosphoinositide 3-kinase and ERK-MAP kinase pathways
- Cell wall-associated ROOT HAIR SPECIFIC 10, a proline-rich receptor-like kinase, is a negative modulator of Arabidopsis root hair growth
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Vandetanib-associated alopecia areata in a patient with metastatic medullary thyroid cancer
- Protein Kinase C as a Therapeutic Target
- TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia
- MIM and Cortactin Antagonism Regulates Ciliogenesis and Hedgehog Signaling
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
- Epidermal Growth Factor as a Biologic Switch in Hair Growth Cycle
- An ERK-dependent molecular switch antagonizes fibrosis and promotes regeneration in spiny mice ( <i>Acomys</i> )
- Regulation and Role of GLI1 in Cutaneous Squamous Cell Carcinoma Pathogenesis
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- ENZYMES
- Enzymes
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- TREMendous Macrophages Inhibit Hair Growth
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Migration Inhibitory Factor in Conditioned Medium from Human Umbilical Cord Blood-Derived Mesenchymal Stromal Cells Stimulates Hair Growth
- Prevention of Chemotherapy-Induced Alopecia in Rats by CDK Inhibitors